Related Experiment Video
Updated: Jun 13, 2026
07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
Bariatric surgery and the gut hormone response
1Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH 44195, USA. thomass4@ccf.org
Summary
Bariatric surgery promotes significant long-term weight loss and remission of obesity-related diseases by altering gut hormones. Further research into these metabolic changes may lead to less invasive treatments.
Area of Science:
- Metabolic surgery
- Obesity medicine
- Gastroenterology
Background:
- Obesity is a global epidemic with significant health consequences, including increased risk for numerous diseases.
- Current weight loss therapies (medical, psychological, endoscopic) offer modest results with common weight regain.
- Bariatric surgery is the most effective intervention for substantial, long-term weight loss and comorbidity resolution.
Purpose of the Study:
- To explore the mechanisms behind bariatric surgery's effectiveness in weight loss and comorbidity remission.
- To investigate the role of altered gut hormones in post-bariatric surgery metabolic changes.
- To review current hypotheses explaining these metabolic alterations.
Main Methods:
- Review of existing literature on bariatric surgery outcomes.
- Analysis of proposed hypotheses (hindgut and foregut) for metabolic changes.
- Discussion of the impact of gut hormone alterations on glucose metabolism and insulin resistance.
Main Results:
- Bariatric surgery achieves 35%-40% weight loss lasting up to 15 years, with rapid initial weight reduction.
- Significant remission of obesity-related comorbidities is frequently observed post-surgery.
- Metabolic changes, particularly gut hormone alterations, are strongly linked to surgical weight loss, though not fully understood.
Conclusions:
- Bariatric surgery is highly effective for long-term weight management and improving obesity-related health conditions.
- Gut hormone alterations following surgery play a crucial role in metabolic improvements, with ongoing research to elucidate mechanisms.
- Further investigation could pave the way for novel, less invasive therapeutic strategies for obesity and related disorders.
Related Concept Videos
01:40Hormonal Regulation
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:22Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:25Regulation of the Digestive System
Digestive activity regulation hinges on three primary components. Activation is prompted by a multitude of mechanical and chemical indicators, primarily detected by receptors within the stomach and intestines' walls. These receptors predominantly respond to factors such as mechanical stretching of the organ walls, changes in pH and osmolarity, and the presence of digesting materials and their by-products.
The effectors in this regulation system are glands and smooth muscles. Activation of these...
The effectors in this regulation system are glands and smooth muscles. Activation of these...